phase 2_initiation
saveNovo Nordisk AS — zalfermin (Phase II Trial Initiation)
community read0 votes
Therapy area: Gastrointestinal. Indication: Liver Failure (Hepatic Insufficiency)
Data sources
globaldata
Found something off?
same company · ±60 days · 6
- phase 1 initiationcagrilintide hydrochloride: Novo Nordisk AS — cagrilintide hydrochloride (Phase I Trial Initiation)Apr 28, 2026
- approvalWEGOVY (SEMAGLUTIDE) — FDA approvalMar 19, 2026
- approvalWEGOVY (SEMAGLUTIDE) — FDA approvalMar 19, 2026
- recallHarbin Jixianglong Biotech Co., Ltd. recall (Cls II)Mar 11, 2026
- recallHarbin Jixianglong Biotech Co., Ltd. recall (Cls II)Mar 11, 2026
- approvalWEGOVY (SEMAGLUTIDE) — FDA approvalFeb 25, 2026
comments(0)
5-min edit window · permanent after that